Tarsus Pharmaceuticals (TARS) Appoints Kate Goodrich to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. WDC
2. DECK
3. RNG
4. BYD
5. WCN
6. SPOT
7. FIX
8. BE
9. BMY
10. NDAQ

Go back to Tarsus Pharmaceuticals (TARS) Appoints Kate Goodrich to its Board

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

November 13, 2024 8:30 AM EST

Humana CMO brings more than two decades of experience driving innovative, value-based initiatives designed to improve patient outcomes

IRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the appointment of Katherine H. (Kate) Goodrich, M.D., MHS, Chief Medical Officer of Humana Inc., to its Board of Directors. Dr. Goodrich is a seasoned executive and practicing physician who... More